Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
24,604,030
-
Shares change
-
+2,143,733
-
Total reported value, excl. options
-
$400,575,953
-
Value change
-
+$35,473,049
-
Put/Call ratio
-
116%
-
Number of buys
-
60
-
Number of sells
-
-69
-
Price
-
$16.29
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q4 2021
189 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q4 2021.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,604,030 shares
.
Largest 10 shareholders include STATE STREET CORP (3,254,266 shares), FMR LLC (2,478,822 shares), BlackRock Inc. (2,232,092 shares), VANGUARD GROUP INC (1,971,759 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,233,000 shares), Samsara BioCapital, LLC (640,688 shares), MACQUARIE GROUP LTD (617,497 shares), JACOBS LEVY EQUITY MANAGEMENT, INC (588,922 shares), MILLENNIUM MANAGEMENT LLC (559,678 shares), and TWO SIGMA ADVISERS, LP (549,600 shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.